ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Data Management"

  • Abstract Number: 1005 • ACR Convergence 2024

    Pharmacosurvellience Study of FDA Adverse Event Reporting System (FAERS) Events of Tofacitinib and Upadacitinib

    Nur Barlas, Sait Barlas, Stefan Milutinovic and Shristi Basnyat, Florida State University College of Medicine Internal Medicine Residency Program at Lee Health, Cape Coral

    Background/Purpose: Janus Kinase (JAK) inhibitors are the agents of choice for the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis when other DMARDs are…
  • Abstract Number: 1044 • ACR Convergence 2024

    Analysis of Rheumatic Patients’ Self – Reported Symptoms in Free Written Text Using Natural Language Processing

    Inés Pérez - Sancristóbal1, Nils Steinz2, Ling Qin2, Tjardo Maarseveen3, Floor Zegers4 and Rachel Knevel2, 1Department of Rheumatology, Hospital Clinico San Carlos,, Madrid, Madrid, Spain, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Wormerveer, Netherlands, 4Deparment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Patient-reported symptoms are crucial for medical anamnesis. Digital symptom checkers often use fixed questions, thereby potentially overlooking relevant symptoms. However, the reliability of self-reported…
  • Abstract Number: 1236 • ACR Convergence 2024

    A Novel Role for Artificial Intelligence in Detecting Distinctive Scleroderma Facial Features

    yossra suliman1 and daniel Furst2, 1Assiut university hospital, assiut, Egypt, 2Pacific Arthritis Center, Inglewood

    Background/Purpose: Scleroderma (SSc) is a rare autoimmune fibrosing disease with high rates of morbidity and mortality. Scleroderma is usually diagnosed by rheumatologists and/or dermatologists. However,…
  • Abstract Number: 1570 • ACR Convergence 2024

    Deconvolution of the Lipidomic Signature of Very Early Diagnosis of Systemic Sclerosis (VEDOSS) and Established Disease: Lipid Biomarker Features That Predict Disease Progression in Skin and Lung

    Sunhwa Kim1, Yingtao Bi2, Vishal Kakkar3, Rebecca Ross4 and Francesco Del Galdo3, 1AbbVie, South San Francisco, CA, 2Abbvie, Worcester, MA, 3University of Leeds, Leeds, United Kingdom, 4Medicine and Health, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Systemic sclerosis (SSc) is a heterogeneous autoimmune disease with variable clinical presentations and progression rates. Accurate patient stratification is crucial for optimizing treatment strategies.…
  • Abstract Number: 1722 • ACR Convergence 2024

    Machine Learning-based Risk Stratification Tool to Predict Early Flare for Rheumatic and Musculoskeletal Diseases

    Pradip Moon1, Weizi Li1, Antoni Chan2 and Eghosa Bazuaye2, 1University of Reading, Reading, United Kingdom, 2Royal Berkshire NHS Foundation Trust, Reading, United Kingdom

    Background/Purpose: Rheumatic and musculoskeletal diseases (RMD) affect up to one-third of the UK population and are the number one cause of disability and one of…
  • Abstract Number: 0383 • ACR Convergence 2023

    Identification of Contributing Factors to Difficult-to-Treat Rheumatoid Arthritis (D2T RA) in a Cohort of 972 Patients Using a Natural Language Processing (NLP) Approach

    Hugo BERGIER1, Thibaut Fabacher2, Nathanaël Sedmak2, Erik Sauleau2 and Jacques-Eric Gottenberg3, 1Hautepierre Hospital, Strasbourg, France, 2Hôpitaux Universitaires de Strasbourg, Strasbourg, France, 3Rheumatology Department, Strasbourg University Hospital, Strasbourg, France

    Background/Purpose: Natural Language Processing (NLP), an interdisciplinary field combining artificial intelligence and language science, has gained significant interest in the medical domain for automated collection…
  • Abstract Number: 0498 • ACR Convergence 2023

    Biological Therapies for Psoriasis and Psoriatic Arthritis- effects on Future Risk Development of Major Adverse Cardiovascular Events (MACE)

    Arad Dotan1, Niv Ben-Shabbat1, Abdulla watad2, Dennis McGonagle3 and Howard AMITAL2, 1Department of Medicine 'B'. Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel, 2Sheba Medical Center, Ramat Gan, Israel, 3Leeds Biomedical Research Centre, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Major adverse cardiovascular events (MACE) are known comorbidities and consequences of psoriasis (PsO) and psoriasis arthritis (PsA). Previous studies underlined the potential of immunomodulatory…
  • Abstract Number: 1085 • ACR Convergence 2023

    Utilizing a Maintenance of Certification (MOC) Part 4 Quality Improvement Project to Improve Data Completeness in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry

    Hemalatha Srinivasalu1, anne dennos2, alan Russell3, Mary Beth Son4 and Mara Becker2, 1Children's National Hospital, Washington, DC, 2Duke University, Durham, NC, 3Duke Clinical Research Institute, Duke, NC, 4Division of Immunology, Boston Children's Hospital, Boston, MA

    Background/Purpose: Minimizing missing data in research registries is a universal challenge. Enrolling patients into a research registry with poor data quality is wasteful and potentially…
  • Abstract Number: 1903 • ACR Convergence 2023

    Assessing Disparities Through Missing Race and Ethnicity Data: Results from a Juvenile Arthritis Registry

    Katelyn Banschbach1, Jade Singleton2, Esi Morgan2 and Xing Wang3, 1University of Washington, Seattle, WA, 2Seattle Children's Hospital, Seattle, WA, 3Biostatistics Epidemiology and Analytics in Research (BEAR), Seattle Children’s Research Institute, Seattle, WA

    Background/Purpose: Research databases are missing 25-50% of race and ethnicity, typically related to Black and Hispanic data.1,2The absence of this data can lead to inaccurate…
  • Abstract Number: 2320 • ACR Convergence 2023

    Predicting Remission and Low Disease Activity Attainment in Patients with Systemic Lupus Erythematosus

    Raffaele Da Mutten1, Nursen Cetrez2, Julius Lindblom2, Shereen Oon3, Dionysis Nikolopoulos1, Mandana Nikpour4 and Ioannis Parodis2, 1Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna, Stockholm, Sweden, 2Karolinska Institutet, Stockholm, Sweden, 3St Vincent's Hospital, Fitzroy, Australia, 4The University of Melbourne at St. Vincent’s Hospital Melbourne, Departments of Medicine and Rheumatology, Melbourne, Australia

    Background/Purpose: Response to therapy in SLE varies significantly and presents a considerable challenge in terms of predictability. Development of predictive models with ability to accurately…
  • Abstract Number: 2566 • ACR Convergence 2023

    Comparisons of the Risk of Serious Infections Associated with the Different Classes of Targeted Therapies Used in Psoriatic Arthritis Patients: A Nationwide Cohort Study from the French Health Insurance Database

    Léa Bastard1, pascal claudepierre2, Laetitia Penso3, Emilie Sbidian4 and Laura PINA VEGAS5, 1Henri Mondor University Hospital (APHP) / Rheumatology Department, Créteil, France, 2Universitary Henri Mondor Hospital, Creteil, France, 3Université Paris Est Créteil, Créteil, France, 4Hôpital Henri Mondor, Université Paris Est Créteil, Créteil, France, 5Henri Mondor University Hospital (APHP), Rheumatology Department, Créteil, France

    Background/Purpose: Targeted therapies have demonstrated their efficacy in the treatment of psoriatic arthritis (PsA), with an increased risk of serious infections. However, a comparison of…
  • Abstract Number: PP06 • ACR Convergence 2023

    Dana’s Data Dashboard: Applying a Familiar Framework for Efficient and Effective Health Management

    Dana Guglielmo, Los Angeles, CA

    Background/Purpose: As a researcher and data analyst, I enjoy the meticulous attention to detail that my work requires. I love the process of collecting, analyzing,…
  • Abstract Number: 131 • 2023 Pediatric Rheumatology Symposium

    Improving Methotrexate Documentation in Electronic Health Records – a Quality Improvement Initiative

    Jayne MacMahon1, Jeanine McColl2, Alaa Al-Shehab1, Deborah Levy3, Ronald laxer1 and Shirley Tse1, 1University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada, 2University of Alberta, Edmonton, AB, Canada, 3The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Prescribing methotrexate,is common practice in rheumatology. Appropriate medication counselling and documentation is important. In our province, as per thephysician regulatory body the College of…
  • Abstract Number: 0216 • ACR Convergence 2022

    The Rejected Manuscripts: Its Quality, Its Fate, and Empirical-based Suggestions for Improvement

    Aldo Barajas-Ochoa1, Antonio Cisneros-Barrios2 and Cesar Ramos-Remus3, 1Rutgers New Jersey Medical School., Richmond, VA, 2Universidad de Guadalajara, Guadalajara, Mexico, 3Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico

    Background/Purpose: To assess the quality and performance of manuscripts previously rejected by a rheumatology-focused journal. Methods: This was a cross-sectional, audit-type study of manuscripts submitted…
  • Abstract Number: PP13 • ACR Convergence 2022

    How Becoming Engaged in My Care with Specialized Tools and Support Helped Me Find My Personal Lupus Triggers and Regain Control of My Health

    Tonya Hinton-Green, Philadelphia, PA

    Background/Purpose: My story begins in the ER where I was diagnosed with lupus right after my 22nd birthday.For the next 25 years I went from…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology